Comparable stake leader
VANGUARD CAPITAL MANAGEMENT LLC
SEC ownership of BIO-TECHNE Corp
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000842023.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
31 Mar 2026
- Public ticker
- TECH on Nasdaq
- Parsed ownership sources
- 13D/G, 13F, and 3/4/5
- Largest SEC-reported holder
- VANGUARD CAPITAL MANAGEMENT LLC
- Latest 13D/G holder
- VANGUARD CAPITAL MANAGEMENT LLC
- Latest parsed ownership date
- 31 Mar 2026
- Issuer CIK
- 0000842023
- Issuer location
- Minneapolis, MN
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of BIO-TECHNE Corp (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD CAPITAL MANAGEME...
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
31 Mar 2026
13D/G
13F
3/4/5
Lead comparable stake: 7.4%
13D/G row: VANGUARD CAPITAL MANAGEMENT LLC
Showing 1-8 of 50 holder rows.
Quick read
VANGUARD CAPITAL MANAGEMENT LLC leads the comparable SEC ownership view at 7.4%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD CAPITAL MANAGEMENT LLC's linked filing trail.
Comparable ownership
Top 5
VANGUARD CAPITAL MANAGEMENT LLC
7.4%
BlackRock, Inc.
7%
FMR LLC
5%
PRICE T ROWE ASSOCIATES INC /MD/
2.2%
Roeland Nusse Power
0.03%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
13F
Vanguard Capital Management · Company
|
7.4%
|
$604,103,180
11,559,571 shares
|
$0 | 31 Mar 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
7%
from 13D/G
|
$640,943,435
12,264,513 shares
|
— | 31 Mar 2026 |
| FMR LLC |
13D/G
13F
Company
|
5%
|
$433,946,643
7,859,928 shares
|
$0 | 31 Mar 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13D/G
13F
T. Rowe Price Associates, Inc. · Company
|
2.2%
|
$186,406,005
3,350,818 shares
|
-$305,816,579 | 30 Sep 2025 |
| Roeland Nusse Power |
3/4/5
Director
|
0.03%
|
$2,511,380
44,559 shares
|
-$960,388 | 25 Aug 2025 |
| MORGAN STANLEY |
13F
Company
|
5.4%
|
$445,928,201
8,532,873 shares
|
— | 31 Mar 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13F
Company
|
4.1%
|
$338,662,412
6,480,337 shares
|
— | 31 Mar 2026 |
| STATE STREET CORP |
13F
Company
|
3.7%
|
$306,682,375
5,868,396 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$2,355,384.
Buys
$0
Insiders: 0
Sells
$2,355,384
Insiders: 3
Net
-$2,355,384
Shares: -42,692
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 42,692
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 6,636 | $0 | $320,386 | -$320,386 |
| 3-6 | 0 | 1,976 | $0 | $116,791 | -$116,791 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 34,080 | $0 | $1,918,206 | -$1,918,206 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-19 of 19 reporting-owner rows connected to BIO-TECHNE Corp. Open a relationship link for the CIK-to-CIK filing trail.
Rows
19
Largest Forms 3/4/5 holder
Charles R. Kummeth
Net 12M change
-$2,355,384
Latest report
02 Jun 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Charles R. Kummeth | Chief Executive Officer, Director | $103,771,891 | Mixed | 15 Aug 2023 | ||
| Kim Kelderman Power | Chief Executive Officer, Director | $17,652,357 | Mixed | 05 May 2026 | ||
| James Hippel Power | Cfo | $11,991,954 | Mixed | 05 May 2026 | ||
| William Geist Power | President, Protein Sciences | $5,095,584 | Mixed | 03 Nov 2025 | ||
| John L. Higgins | Director | $3,930,425 | Mixed | 30 Oct 2025 | ||
| Matthew McManus Power | President - Diag & Spatial Bio | $3,811,445 | Mixed | 01 Feb 2026 | ||
| Brenda S. Furlow | Svp General Counsel | $3,481,191 | Mixed | 07 Dec 2022 | ||
| Robert Baumgartner V | Director | $2,797,075 | -$957,818 | -26% | Mixed | 30 Oct 2025 |
| Roeland Nusse Power | Director | $2,511,380 | -$960,388 | -28% | Filing P/S | 25 Aug 2025 |
| Shane Bohnen Power | SVP - General Counsel | $2,275,847 | Mixed | 05 May 2026 | ||
| Randolph C. Steer | Director | $1,873,641 | Mixed | 26 Oct 2023 | ||
| Joseph D. Keegan | Director | $1,067,427 | Mixed | 30 Oct 2025 | ||
| Alpna Seth | Director | $1,067,427 | Mixed | 30 Oct 2025 | ||
| Rupert Vessey | Director | $821,320 | Mixed | 30 Oct 2025 | ||
| Julie L. Bushman | Director | $698,267 | Mixed | 30 Oct 2025 | ||
| Steven C. Crouse | President - Diag & Spatial Bi | $614,043 | Mixed | 02 Jun 2026 | ||
| Judith Klimovsky V | Director | $420,506 | Mixed | 30 Oct 2025 | ||
| Amy E. Herr | Director | $409,695 | -$437,178 | -52% | Mixed | 08 May 2026 |
| Norman David Eansor | President-Protein Sciences | $288,872 | Mixed | 12 Nov 2021 |
Recent insider transactions for BIO-TECHNE Corp
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Steven C. Crouse | TECH | Common Stock | Tax liability | -3.1% | -216 | 6,761 | 02 Jun 2026 | Direct | ||
| Steven C. Crouse | TECH | Common Stock | Options Exercise | 9.41% | 600 | 6,977 | 02 Jun 2026 | Direct | ||
| Steven C. Crouse | TECH | Restricted Stock Units | Options Exercise | -33.3% | -600 | 1,200 | 02 Jun 2026 | Direct | ||
| Amy E. Herr | TECH | Common Stock | Sale | -97.1% | $320,386 | $48.28 | -6,636 | 200 | 08 May 2026 | By significant other |
| Amy E. Herr | TECH | Common Stock | Options Exercise | 3318% | 6,636 | 6,836 | 08 May 2026 | By significant other | ||
| Amy E. Herr | TECH | Stock Option (Right to Buy) | Options Exercise | -100% | -6,636 | 0 | 08 May 2026 | By significant other | ||
| James Hippel Power | TECH | Common Stock | Tax liability | -27% | -56,955 | 153,670 | 05 May 2026 | Direct | ||
| James Hippel Power | TECH | Common Stock | Options Exercise | 41.7% | 62,000 | 210,625 | 05 May 2026 | Direct | ||
| James Hippel Power | TECH | Stock Options (Right to Buy) | Options Exercise | -50% | -62,000 | 62,068 | 05 May 2026 | Direct | ||
| Shane Bohnen Power | TECH | Common Stock | Tax liability | -49.3% | -7,055 | 7,249 | 05 May 2026 | Direct | ||
| Shane Bohnen Power | TECH | Common Stock | Options Exercise | 142.3% | 8,400 | 14,304 | 05 May 2026 | Direct | ||
| Shane Bohnen Power | TECH | Stock Option (Right to Buy) | Options Exercise | -94.9% | -8,400 | 448 | 05 May 2026 | Direct | ||
| Kim Kelderman Power | TECH | Common Stock | Tax liability | -26.7% | -23,951 | 65,799 | 05 May 2026 | Direct | ||
| Kim Kelderman Power | TECH | Common Stock | Options Exercise | 42.3% | 26,692 | 89,750 | 05 May 2026 | Direct | ||
| Kim Kelderman Power | TECH | Stock Option (Right to Buy) | Options Exercise | -43.3% | -26,692 | 35,000 | 05 May 2026 | Direct | ||
| Steven C. Crouse | TECH | Common Stock | Tax liability | -4.68% | -311 | 6,337 | 01 May 2026 | Direct | ||
| Steven C. Crouse | TECH | Common Stock | Options Exercise | 13.5% | 794 | 6,688 | 01 May 2026 | Direct | ||
| Steven C. Crouse | TECH | Restricted Stock Units | Options Exercise | -50% | -794 | 794 | 01 May 2026 | Direct | ||
| Kim Kelderman Power | TECH | Common Stock | Tax liability | -2.12% | -1,363 | 63,058 | 22 Apr 2026 | Direct | ||
| Kim Kelderman Power | TECH | Common Stock | Options Exercise | 21.4% | 11,344 | 64,421 | 22 Apr 2026 | Direct | ||
| Kim Kelderman Power | TECH | Stock Option (Right to Buy) | Options Exercise | -15.5% | -11,344 | 61,692 | 22 Apr 2026 | Direct | ||
| James Hippel Power | TECH | Common Stock | Tax liability | -27.4% | -56,097 | 148,625 | 22 Apr 2026 | Direct | ||
| James Hippel Power | TECH | Common Stock | Options Exercise | 43.4% | 62,000 | 204,722 | 22 Apr 2026 | Direct | ||
| James Hippel Power | TECH | Stock Options (Right to Buy) | Options Exercise | -33.3% | -62,000 | 124,068 | 22 Apr 2026 | Direct | ||
| Kim Kelderman Power | TECH | Common Stock | Tax liability | -37.7% | -32,088 | 53,077 | 14 Apr 2026 | Direct | ||
| Kim Kelderman Power | TECH | Common Stock | Options Exercise | 75% | 36,500 | 85,165 | 14 Apr 2026 | Direct | ||
| Kim Kelderman Power | TECH | Stock Option (Right to Buy) | Options Exercise | -33.3% | -36,500 | 73,036 | 14 Apr 2026 | Direct | ||
| Shane Bohnen | TECH | Common Stock | Tax liability | -11.1% | -740 | 5,904 | 03 Apr 2026 | Direct | ||
| Shane Bohnen | TECH | Common Stock | Options Exercise | 51.5% | 2,259 | 6,644 | 03 Apr 2026 | Direct | ||
| Shane Bohnen | TECH | Restricted Stock Units | Options Exercise | -100% | -2,259 | 0 | 03 Apr 2026 | Direct | ||
| Steven C. Crouse | TECH | Stock Option (right to buy) | Award | 1,911 | 1,911 | 02 Mar 2026 | Direct | |||
| Steven C. Crouse | TECH | Restricted Stock Units | Award | 735 | 735 | 02 Mar 2026 | Direct | |||
| Steven C. Crouse | TECH | Performance Restricted Stock Units | Award | 2,387 | 2,387 | 02 Mar 2026 | Direct | |||
| Amy E. Herr | TECH | Common Stock | Sale | -90.8% | $116,791 | $59.10 | -1,976 | 200 | 17 Feb 2026 | By significant other |
| Amy E. Herr | TECH | Common Stock | Tax liability | -0.73% | -16 | 2,176 | 03 Feb 2026 | By significant other | ||
| Amy E. Herr | TECH | Common Stock | Options Exercise | 1.76% | 38 | 2,192 | 03 Feb 2026 | By significant other | ||
| Amy E. Herr | TECH | Restricted Stock Units | Options Exercise | -33% | -38 | 77 | 03 Feb 2026 | By significant other | ||
| Matthew McManus Power | TECH | Common Stock | Tax liability | -17.8% | -1,665 | 7,691 | 01 Feb 2026 | Direct | ||
| Matthew McManus Power | TECH | Common Stock | Options Exercise | 97.6% | 4,621 | 9,356 | 01 Feb 2026 | Direct | ||
| Matthew McManus Power | TECH | Restricted Stock Units | Options Exercise | -50% | -4,621 | 4,620 | 01 Feb 2026 | Direct | ||
| William Geist Power | TECH | Common Stock | Tax liability | -18.1% | -4,520 | 20,503 | 03 Nov 2025 | Direct | ||
| William Geist Power | TECH | Common Stock | Options Exercise | 65.6% | 9,911 | 25,023 | 03 Nov 2025 | Direct | ||
| William Geist Power | TECH | Restricted Stock Units | Options Exercise | -100% | -9,911 | 0 | 03 Nov 2025 | Direct | ||
| Kim Kelderman Power | TECH | Common Stock | Tax liability | -4.52% | -2,303 | 48,665 | 03 Nov 2025 | Direct | ||
| James Hippel Power | TECH | Common Stock | Tax liability | -7.68% | -11,865 | 142,722 | 03 Nov 2025 | Direct | ||
| James Hippel Power | TECH | Common Stock | Options Exercise | 19% | 24,704 | 154,587 | 03 Nov 2025 | Direct | ||
| James Hippel Power | TECH | Restricted Stock Units | Options Exercise | -100% | -24,704 | 0 | 03 Nov 2025 | Direct | ||
| Amy E. Herr | TECH | Common Stock | Award | 157.7% | 1,640 | 2,680 | 30 Oct 2025 | Direct | ||
| Amy E. Herr | TECH | Stock Option (Right to Buy) | Award | 3,777 | 3,777 | 30 Oct 2025 | Direct | |||
| Judith Klimovsky V | TECH | Common Stock | Award | 76.6% | 1,640 | 3,782 | 30 Oct 2025 | Direct |
* marks a reported price that did not pass the local price check.